Tricuspid atresia epidemiology and demographics: Difference between revisions
(→Age) |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
Worldwide, the prevalence of [[tricuspid atresia]] is 7.8 per 100,000 persons. [[Tricuspid atresia]] is a [[congenital heart disease]] observed among infants at the time of birth. | |||
[[Tricuspid atresia]] affects males and females equally. There is no racial predilection for [[tricuspid atresia]]. | |||
== Epidemiology and Demographics == | == Epidemiology and Demographics == | ||
== Prevalence == | === Prevalence === | ||
*Worldwide, the prevalence of [[tricuspid atresia]] is 7.8 per 100,000 persons.<ref name="LiuChen2019">{{cite journal|last1=Liu|first1=Yingjuan|last2=Chen|first2=Sen|last3=Zühlke|first3=Liesl|last4=Black|first4=Graeme C|last5=Choy|first5=Mun-kit|last6=Li|first6=Ningxiu|last7=Keavney|first7=Bernard D|title=Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies|journal=International Journal of Epidemiology|volume=48|issue=2|year=2019|pages=455–463|issn=0300-5771|doi=10.1093/ije/dyz009}}</ref> | *Worldwide, the prevalence of [[tricuspid atresia]] is 7.8 per 100,000 persons.<ref name="LiuChen2019">{{cite journal|last1=Liu|first1=Yingjuan|last2=Chen|first2=Sen|last3=Zühlke|first3=Liesl|last4=Black|first4=Graeme C|last5=Choy|first5=Mun-kit|last6=Li|first6=Ningxiu|last7=Keavney|first7=Bernard D|title=Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies|journal=International Journal of Epidemiology|volume=48|issue=2|year=2019|pages=455–463|issn=0300-5771|doi=10.1093/ije/dyz009}}</ref> | ||
== Age == | === Age === | ||
*[[Tricuspid atresia]] is | *[[Tricuspid atresia]] is a [[congenital heart disease]] observed among infants at the time of birth. | ||
== Gender == | === Gender === | ||
*Tricuspid atresia affects males and females equally. | *Tricuspid atresia affects males and females equally. | ||
== Race == | === Race === | ||
*There is no racial predilection for tricuspid atresia | *There is no racial predilection for [[tricuspid atresia]] | ||
==References== | ==References== | ||
Latest revision as of 16:00, 8 November 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia epidemiology and demographics |
|
Risk calculators and risk factors for Tricuspid atresia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Sara Zand, M.D.[2] Keri Shafer, M.D. [3] Priyamvada Singh, MBBS [4]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [5]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Worldwide, the prevalence of tricuspid atresia is 7.8 per 100,000 persons. Tricuspid atresia is a congenital heart disease observed among infants at the time of birth. Tricuspid atresia affects males and females equally. There is no racial predilection for tricuspid atresia.
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of tricuspid atresia is 7.8 per 100,000 persons.[1]
Age
- Tricuspid atresia is a congenital heart disease observed among infants at the time of birth.
Gender
- Tricuspid atresia affects males and females equally.
Race
- There is no racial predilection for tricuspid atresia
References
- ↑ Liu, Yingjuan; Chen, Sen; Zühlke, Liesl; Black, Graeme C; Choy, Mun-kit; Li, Ningxiu; Keavney, Bernard D (2019). "Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies". International Journal of Epidemiology. 48 (2): 455–463. doi:10.1093/ije/dyz009. ISSN 0300-5771.